Clinical Trials Directory

Trials / Unknown

UnknownNCT01149187

Usefulness of Interferon-gamma Release Assay in Diagnosing Pulmonary Nodules

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Among the causes of the solitary pulmonary nodule (SPN), benign causes including tuberculosis was noted on 15 to 60 percents in various studies. Although the characteristics of chest imaging is helpful in diagnosis and percutaneous needle biopsy for pulmonary nodule has been represented high diagnostic yield in many reports, but still surgical biopsy has been needed in definite diagnosis of pulmonary nodules in many cases. The aim of this study is to evaluate the usefulness of interferon-gamma release assay in addition to the percutaneous needle biopsy, in diagnosis of pulmonary nodules.

Detailed description

Among the patients who failed to diagnosis by percutaneous needle biopsy and needed to have Surgical biopsy, thirty percents of the patients were diagnosed as benign nodules and about six percents were diagnosed as tuberculosis in Seoul National University Hospital during 2007-2008. The investigators want to know whether conducting an interferon-gamma release assay in addition to percutaneous needle biopsy is helpful in diagnosis of lung nodules.

Conditions

Timeline

Start date
2010-06-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2010-06-23
Last updated
2010-06-23

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01149187. Inclusion in this directory is not an endorsement.

Usefulness of Interferon-gamma Release Assay in Diagnosing Pulmonary Nodules (NCT01149187) · Clinical Trials Directory